Others have shown that in order to generate mouse models of GBA1-PD, it has been necessary to introduce a secondary burden such as under-expression of prosaposin [22], over-expression of pathological alpha-synuclein [26] or injection of pre-formed fibrils [24]. This evidence concerns the gene PSAP and Parkinson disease.